Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) FCF Margin (2016 - 2025)

Historic FCF Margin for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to 31.92%.

  • Cryo Cell International's FCF Margin rose 40100.0% to 31.92% in Q3 2025 from the same period last year, while for Aug 2025 it was 19.48%, marking a year-over-year increase of 97800.0%. This contributed to the annual value of 11.28% for FY2024, which is 46400.0% up from last year.
  • According to the latest figures from Q3 2025, Cryo Cell International's FCF Margin is 31.92%, which was up 40100.0% from 8.13% recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's FCF Margin peaked at 38.63% during Q1 2021, and registered a low of 111.31% during Q3 2022.
  • Over the past 5 years, Cryo Cell International's median FCF Margin value was 16.21% (recorded in 2023), while the average stood at 8.52%.
  • In the last 5 years, Cryo Cell International's FCF Margin crashed by -1183500bps in 2022 and then soared by 941800bps in 2023.
  • Quarter analysis of 5 years shows Cryo Cell International's FCF Margin stood at 18.97% in 2021, then skyrocketed by 67bps to 31.62% in 2022, then plummeted by -35bps to 20.69% in 2023, then grew by 29bps to 26.78% in 2024, then increased by 19bps to 31.92% in 2025.
  • Its FCF Margin stands at 31.92% for Q3 2025, versus 8.13% for Q2 2025 and 11.19% for Q1 2025.